| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2726145 | The American Journal of Medicine | 2006 | 8 Pages |
Abstract
Screening average-risk populations for colorectal cancer can reduce the incidence and mortality of colorectal cancer. Effectiveness depends on programmatic adherence and quality. This review discusses the evidence supporting the use of currently available screening tests. The discussion specifically focuses on programmatic issues and highlights the importance of quality assurance in each program.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
David Lieberman,